200 related articles for article (PubMed ID: 35956339)
1. Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores.
Tsai TY; Hsu PF; Wu CH; Huang SS; Chan WL; Lin SJ; Chen JW; Lu TM; Leu HB
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956339
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease.
Song DS; Chang UI; Kang SG; Song SW; Yang JM
Gut Liver; 2019 Nov; 13(6):658-668. PubMed ID: 30970434
[TBL] [Abstract][Full Text] [Related]
3. Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease.
Lu C; Chen Y; Zhang Y; Zhao X
Diabetes Metab Syndr Obes; 2023; 16():2627-2637. PubMed ID: 37663203
[TBL] [Abstract][Full Text] [Related]
4. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease.
Lee J; Kim HS; Cho YK; Kim EH; Lee MJ; Bae IY; Jung CH; Park JY; Kim HK; Lee WJ
Sci Rep; 2020 Oct; 10(1):18323. PubMed ID: 33110139
[TBL] [Abstract][Full Text] [Related]
5. The association of the steatosis severity in fatty liver disease with coronary plaque pattern in general population.
Hsu PF; Wang YW; Lin CC; Wang YJ; Ding YZ; Liou TL; Huang SS; Lu TM; Chan WL; Lin SJ; Leu HB
Liver Int; 2021 Jan; 41(1):81-90. PubMed ID: 33373113
[TBL] [Abstract][Full Text] [Related]
6. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
[TBL] [Abstract][Full Text] [Related]
7. Liver fibrosis scores and coronary atherosclerosis: novel findings in patients with stable coronary artery disease.
Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Cui CJ; Liu G; Sun J; Dong Q; Li JJ
Hepatol Int; 2021 Apr; 15(2):413-423. PubMed ID: 33740211
[TBL] [Abstract][Full Text] [Related]
8. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial.
Puchner SB; Lu MT; Mayrhofer T; Liu T; Pursnani A; Ghoshhajra BB; Truong QA; Wiviott SD; Fleg JL; Hoffmann U; Ferencik M
Radiology; 2015 Mar; 274(3):693-701. PubMed ID: 25369449
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease.
Hollenberg EJ; Lin F; Blaha MJ; Budoff MJ; van den Hoogen IJ; Gianni U; Lu Y; Bax AM; van Rosendael AR; Tantawy SW; Andreini D; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; de Araújo Gonçalves P; Hadamitzky M; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Gimelli A; Lee SE; Bax JJ; Berman DS; Sellers SL; Leipsic JA; Blankstein R; Narula J; Chang HJ; Shaw LJ
JACC Cardiovasc Imaging; 2022 Jun; 15(6):1063-1074. PubMed ID: 35680215
[TBL] [Abstract][Full Text] [Related]
11. The Nonalcoholic Fatty Liver Disease Fibrosis Score Is Related to Epicardial Fat Thickness and Complexity of Coronary Artery Disease.
Turan Y
Angiology; 2020 Jan; 71(1):77-82. PubMed ID: 31018673
[TBL] [Abstract][Full Text] [Related]
12. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease.
Chen Q; Li Q; Li D; Chen X; Liu Z; Hu G; Wang J; Ling W
Atherosclerosis; 2020 Apr; 299():45-52. PubMed ID: 32240838
[TBL] [Abstract][Full Text] [Related]
13. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation.
Tan SH; Zhou XL
Clinics (Sao Paulo); 2023; 78():100301. PubMed ID: 37952443
[TBL] [Abstract][Full Text] [Related]
14. Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry.
Al-Mallah MH; Qureshi W; Lin FY; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Chang HJ; Cademartiri F; Chinnaiyan K; Chow BJ; Cheng VY; Delago A; Gomez M; Hadamitzky M; Hausleiter J; Kaufmann PA; Leipsic J; Maffei E; Raff G; Shaw LJ; Villines TC; Cury RC; Feuchtner G; Plank F; Kim YJ; Dunning AM; Min JK
Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):267-74. PubMed ID: 23966421
[TBL] [Abstract][Full Text] [Related]
15. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
[TBL] [Abstract][Full Text] [Related]
16. Presence, Characteristics, and Volumes of Coronary Plaque Determined by Computed Tomography Angiography in Young Type 2 Diabetes Mellitus.
Nezarat N; Budoff MJ; Luo Y; Darabian S; Nakanishi R; Li D; Sheidaee N; Kim M; Alani A; Matsumoto S; Rahmani S; Kanisawa M; Ceponiene I; Osawa K; Qi H; Hamal S; Kitslaar P; Broersen A; Flores F; Ipp E; Khazai B
Am J Cardiol; 2017 May; 119(10):1566-1571. PubMed ID: 28343599
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage.
Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ;
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027
[TBL] [Abstract][Full Text] [Related]
18. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease.
Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N
J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133
[TBL] [Abstract][Full Text] [Related]
20. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.
Hsiao CC; Teng PH; Wu YJ; Shen YW; Mar GY; Wu FZ
BMC Cardiovasc Disord; 2021 May; 21(1):244. PubMed ID: 34011282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
